Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.
Abnormal activation of PI3K/AKT/mTOR (PAM) pathway, caused by PIK3CA mutation, KRAS mutation, PTEN loss, or AKT1 mutation, is one of the most frequent signaling abnormalities in breast carcinoma. However, distribution and frequencies of mutations in PAM pathway are unclear in breast cancer patients...
Main Authors: | Ling Deng, Jie Chen, Xiao Rong Zhong, Ting Luo, Yan Ping Wang, Hui Fen Huang, Li-Juan Yin, Yan Qiu, Hong Bu, Qing Lv, Hong Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4376391?pdf=render |
Similar Items
-
PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
by: Kunrui Zhu, et al.
Published: (2022-08-01) -
PI3K/AKT/mTOR pathway in Angiogenesis
by: Jayashree eKarar, et al.
Published: (2011-12-01) -
Targeting PI3K/Akt/mTOR Signaling In Cancer
by: Camillo ePorta, et al.
Published: (2014-04-01) -
PI3K/Akt/mTOR inhibitors in breast cancer
by: Joycelyn JX Lee, et al.
Published: (2015-12-01) -
Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula
by: Stefano Ratti, et al.
Published: (2022-02-01)